Guidance for Neuronetics (STIM)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2025 | N/A | N/A | $147.00M – 150.00M | $151.00M | = Maintained | Details |
| 2025 | N/A | N/A | $149.00M – 155.00M | $151.00M | = Maintained | Details |
| 2025 | N/A | N/A | $149.00M – 155.00M | $148.60M | = Maintained | Details |
| 2025 | N/A | N/A | $145.00M – 155.00M | $145.00M | = Maintained | Details |
| Q4 2025 | N/A | N/A | $40.00M – 80.00M | $43.06M | = Maintained | Details |
| Q3 2025 | N/A | N/A | $37.00M – 39.00M | $38.22M | = Maintained | Details |
| Q2 2025 | N/A | N/A | $36.00M – 38.00M | $36.69M | = Maintained | Details |
| Q1 2025 | N/A | N/A | $28.00M – 30.00M | $28.80M | = Maintained | Details |
| 2024 | N/A | N/A | $71.00M – 72.00M | $77.92M | = Maintained | Details |
| 2024 | N/A | N/A | $78.00M – 80.00M | $79.14M | = Maintained | Details |
| 2024 | N/A | N/A | $78.00M – 80.00M | $79.12M | = Maintained | Details |
| 2024 | N/A | N/A | $78.00M – 80.00M | $78.64M | = Maintained | Details |
| Q4 2024 | N/A | N/A | $19.00M – 20.00M | $24.90M | = Maintained | Details |
| Q3 2024 | N/A | N/A | $18.50M – 19.50M | $20.12M | = Maintained | Details |
| Q2 2024 | N/A | N/A | $18.00M – 19.00M | $19.46M | = Maintained | Details |
| Q1 2024 | N/A | N/A | $16.70M – 17.70M | $16.98M | = Maintained | Details |
| 2023 | N/A | N/A | $68.00M – 73.00M | $68.70M | = Maintained | Details |
| 2022 | N/A | N/A | $63.00M – 64.00M | $61.79M | = Maintained | Details |
